IMRX

Immuneering Corp

Pharmaceutical PreparationsNasdaq<br>Emerging growth company

Total Trades

38

Buys

34

Sells

1

Largest Trade

$1M+

Insiders

14

Institutional Funds

66

Inst. Value

$1M+

Activist Filings

24

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Brakewood Harold EugeneChief Business Off…BUY$15K–$50K5K$4.76Jan 21, 2026
Schall Thomas J.DirectorBUY$100K–$500K22K$4.67Jan 20, 2026
Hall Brett MatthewCHIEF SCIENTIFIC O…BUY$1K–$15K2K$4.57Jan 16, 2026
Neufeld Leah RCHIEF PEOPLE OFFICERBUY$1K–$15K3K$4.15Jan 15, 2026
Feinberg PeterDirectorBUY$50K–$100K20K$4.35Jan 14, 2026
Morales MalloryChief Accounting O…BUY$1K–$15K300$6.39Oct 2, 2025
Neufeld Leah RCHIEF PEOPLE OFFICERBUY$1K–$15K800$6.38Oct 2, 2025
Bookman MichaelCHIEF LEGAL OFFICERBUY$1K–$15K1K$6.83Oct 2, 2025
Feinberg PeterDirectorBUY$50K–$100K8K$7.03Oct 1, 2025
Feinberg PeterDirectorBUY$15K–$50K5K$7.18Sep 30, 2025
HAUSMAN DIANADirectorBUY$15K–$50K6K$3.61Jul 7, 2025
Neufeld Leah RCHIEF PEOPLE OFFICERBUY$1K–$15K700$3.57Jul 7, 2025
Zeskind Benjamin J.PRESIDENT AND CEOBUY$15K–$50K10K$3.49Jul 3, 2025
Schall Thomas J.DirectorBUY$15K–$50K10K$3.66Jun 30, 2025
Hall Brett MatthewCHIEF SCIENTIFIC O…BUY$15K–$50K13K$2.58Jun 24, 2025
Brakewood Harold EugeneChief Business Off…BUY$1K–$15K2K$2.53Jun 24, 2025
Feinberg PeterDirectorBUY$50K–$100K25K$2.53Jun 23, 2025
Zeskind Benjamin J.PRESIDENT AND CEOBUY$50K–$100K21K$2.39Jun 20, 2025
Schall Thomas J.DirectorBUY$50K–$100K40K$2.21Jun 18, 2025
Cormorant Asset Management, LP10% OwnerSELL$1M+400K$2.90Apr 3, 2024
Schall Thomas J.DirectorBUY$1K–$15K3K$2.55Mar 25, 2024
Feinberg PeterDirectorBUY$50K–$100K25K$2.55Mar 25, 2024
Brakewood Harold EugeneChief Business Off…BUY$1K–$15K4K$2.57Mar 25, 2024
Morales MalloryChief Accounting O…BUY$1K–$15K2K$2.67Mar 25, 2024
Morales MalloryChief Accounting O…GRANT$1K–$15K4K$1.62Mar 25, 2024
Neufeld Leah RCHIEF PEOPLE OFFICERGRANT$1K–$15K6K$1.62Mar 21, 2024
Neufeld Leah RCHIEF PEOPLE OFFICERBUY$1K–$15K4K$2.88Mar 21, 2024
Hall Brett MatthewCHIEF SCIENTIFIC O…BUY$15K–$50K7K$2.86Mar 21, 2024
Hall Brett MatthewCHIEF SCIENTIFIC O…GRANT$1K–$15K6K$1.62Mar 21, 2024
Hall Brett MatthewCHIEF SCIENTIFIC O…BUY$1K–$15K3K$3.92May 27, 2022
Bookman MichaelGENERAL COUNSEL AN…BUY$1K–$15K1K$4.88May 18, 2022
KEATING LAURIEDirectorBUY$15K–$50K7K$5.00May 17, 2022
Amin BirenCFO, TREASURERBUY$1K–$15K1K$4.42May 12, 2022
Zeskind Benjamin J.PRESIDENT AND CEOBUY$15K–$50K3K$8.02Mar 24, 2022
Hall Brett MatthewCHIEF SCIENTIFIC O…BUY$1K–$15K1K$7.91Mar 23, 2022
Barrett ScottCHIEF MEDICAL OFFI…BUY$1K–$15K900$7.49Mar 22, 2022
Feinberg PeterDirectorBUY$15K–$50K7K$6.75Mar 16, 2022
BERMAN ANN EDirectorBUY$15K–$50K6K$6.40Mar 15, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

BENJAMIN J. ZESKIND

SC 13G/A · Jan 22, 2026

6.6%

4.4M shares

Empery Asset Management, LP

SC 13G/A · Jan 15, 2026

5.0%

3.3M shares

Empery Asset Management, LP

SC 13G · Oct 21, 2025

8.8%

5.2M shares

FMR LLC

SC 13G · Oct 7, 2025

14.5%

8.8M shares

5.7%

3.6M shares

BENJAMIN J. ZESKIND

SC 13G/A · Jan 17, 2025

12.8%

4.0M shares

Citadel Advisors LLC

SC 13G/A · Nov 14, 2024

0.0%

6 shares

Cormorant Asset Management, LP

SC 13G/A · Nov 14, 2024

0.0%

0 shares

1.9%

561K shares

3.1%

910K shares

BlackRock, Inc.

SC 13G/A · Apr 5, 2024

4.7%

1.4M shares

Merrin Investors LLC

SC 13G/A · Mar 27, 2024

9.5%

2.8M shares

Citadel Advisors LLC

SC 13G/A · Feb 14, 2024

7.0%

6 shares

11.5%

3.4M shares

BlackRock, Inc.

SC 13G · Jan 26, 2024

7.2%

2.1M shares

BlackRock, Inc.

SC 13G/A · May 5, 2023

4.6%

1.3M shares

6.8%

2.0M shares

3.7%

988K shares

13.7%

3.6M shares

Citadel Advisors LLC

SC 13G/A · Feb 14, 2023

7.8%

6 shares

BlackRock, Inc.

SC 13G/A · Feb 1, 2023

5.1%

1.3M shares

12.2%

3.2M shares

Citadel Advisors LLC

SC 13G/A · Feb 14, 2022

7.8%

6 shares

Benjamin J. Zeskind

SC 13G · Feb 10, 2022

12.7%

3.4M shares

View on Google Finance →